EduBourseActualitésAgilent Technologies Appoints The Research Institute at Nationwide Children's Hospital as Certified...

Agilent Technologies Appoints The Research Institute at Nationwide Children’s Hospital as Certified Service Provider for Microarrays

Agilent Technologies Inc. (NYSE: A) today announced that The Research Institute at Nationwide Children’s Hospital has achieved Certified Service Provider (CSP) status for Agilent microarrays. Certification is for array-based comparative genomic hybridization (aCGH) and gene expression assays on the Agilent platform. These microarrays are used to investigate the relationships between genes and health.

“It’s very gratifying to see a major academic core research facility take the extra step of achieving CSP status, as this will leverage their expertise and the benefits of the technology to a wider range of disease researchers,” said Chris Grimley, Agilent senior marketing director, Genomics. “Investigators demand the highest degree of proficiency when they send precious samples for microarray analysis, and The Research Institute at Nationwide Children’s hospital is responding to their needs in this highly competitive field.”

“We provide our clients with a complete solution for their genomics research, from the initial steps of experimental design to the production of high-quality, comprehensively analyzed data sets,” said Peter White, Ph.D., director of the Biomedical Genomics Core, The Research Institute at Nationwide Children’s Hospital. “The investigators working with us have been tremendously happy with the data we produce, which has led to rapidly growing demand for our Agilent gene expression and CGH services. We’re committed to producing publication-quality data sets and so obtaining CSP status was the logical next step for us. In line with our institute’s mission to ‘enhance the health of children by engaging in high-quality, cutting-edge research according to the highest scientific and ethical standards,’ the CSP program provides us with a way of assuring our clients that they are getting the best possible service.”

The institute achieved Agilent-certified status after completing training and passing a rigorous series of assessments that included demonstrating proficiency in:

analyzing Agilent’s 60-mer oligo microarrays using the complete Agilent system of reagents and instrumentation;
maintaining sample quality control using the Agilent 2100 Bioanalyzer;
analyzing data using the GeneSpring bioinformatics platform.
Gene expression microarrays enable researchers to observe which genes are “turned on” and “off,” and is the most popular microarray application. aCGH measures extra copies or missing sections in the genome, which are increasingly being associated with a number of widespread disorders.

About Agilent in Genomics

Agilent is a leading worldwide provider of microarray-based, genomics research solutions. Agilent’s end-to-end solution includes reagents for sample preparation and microarray processing; hardware for sample QC and high-throughput microarray scanning; 60-mer oligo microarrays on industry-standard 1″ x 3″ glass slides for gene expression; comparative genomic hybridization, microRNA, splice variants and chromatin immunoprecipitation applications; custom microarray design services; target enrichment kit to streamline next-generation sequencing and industry-leading GeneSpring software products for data analysis.

About The Research Institute at Nationwide Children’s Hospital

Ranked in the U.S. News & World Report’s 2008 “America’s Best Children’s Hospitals” and Parents Magazine’s 2009 top 10 “Best Children’s Hospitals” lists, Nationwide Children’s Hospital is one of the nation’s largest not- for-profit freestanding pediatric healthcare networks providing care for infants, children, adolescents and adult patients with congenital disease. As home to the Department of Pediatrics of The Ohio State University College of Medicine, Nationwide Children’s Hospital physicians train the next generation of pediatricians and pediatric specialists. The Research Institute at Nationwide Children’s Hospital is one of the top 10 National Institutes of Health-funded free-standing pediatric research facilities in the U.S., supporting basic, clinical, translational and health services research activities at Nationwide Children’s Hospital. With more than 300,000 square feet of dedicated research space, The Research Institute is organized into 13 Centers of Emphasis encompassing gene therapy; molecular and human genetics; vaccines and immunity; childhood cancer; cell and developmental biology; perinatal research; injury research and policy; microbial pathogenesis; cardiovascular and pulmonary research; mathematical medicine; biobehavioral health, innovation in pediatric practice; and clinical and translational research. Nationwide Children’s remains true to its original mission since its founding in 1892 of providing care regardless of a family’s ability to pay. More information is available at www.NationwideChildrens.org/research.

——————————————————————————–
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is the world’s premier measurement company and a technology leader in communications, electronics, life sciences and chemical analysis. The company’s 19,000 employees serve customers in more than 110 countries. Agilent had net revenues of $5.8 billion in fiscal 2008. Information about Agilent is available on the Web at www.agilent.com.

# # #

Contact:

Stuart Matlow, Agilent
+1 408 553 7191
[email protected]

Pam Barber, The Research Institute at Nationwide Children’s Hospital
+1 614 355 0485
[email protected]

Pierre Perrin-Monlouis
Pierre Perrin-Monlouis
Fondateur de Rente et Patrimoine (cabinet de gestion de patrimoine), Pierre Perrin-Monlouis est un analyste et trader pour compte propre. Il vous fait profiter de son expérience en trading grâce à ses analyses financières et décrypte pour vous les actualités des marchés. Son approche globale des marchés combine à la fois l'analyse technique et l'analyse fondamentale sur l'ensemble des marchés : crypto, forex, actions et matières premières.
ARTICLES SIMILAIRES
1200
1200